This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Long-term Benefit

Shari DeSilva, MD; Daniel B. Drachman, MD; David Mellits, ScD; Ralph W. Kuncl, MD, PhD

Arch Neurol. 1987;44(8):818-822.

Abstract
• We report the long-term results of a therapeutic trial of prednisone in the treatment of Duchenne muscular dystrophy, comparing the age at which 16 treated patients and 38 controls lost the ability to ambulate. Survival curve analysis and group mean comparisons indicate that ambulation was significantly prolonged, by approximately two years, in the prednisone-treated group compared with the control group. The results of this study indicate that prednisone therapy has a long-term beneficial effect in the treatment of Duchenne muscular dystrophy, in addition to the short-term palliation we previously reported. Further studies are needed to establish optimal treatment schedules using prednisone and to develop improved therapeutic agents.

Author Affiliations
From the Department of Neurology, Neuromuscular Division, The Johns Hopkins University School of Medicine, Baltimore.

Footnotes
Accepted for publication April 21, 1987.

Reprint requests to Department of Neurology, The Johns Hopkins University School of Medicine, Meyer 5-119, 600 N Wolfe St, Baltimore, MD 21205 (Dr Drachman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
King et al.
Neurology 2007;68:1607-1613.
ABSTRACT | FULL TEXT  

The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy
Bonifati et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1177-1179.
ABSTRACT | FULL TEXT  

Steroid Treatment for Cardiac Function in Duchenne Muscular Dystrophy
Danford
AAP Grand Rounds 2006;15:58-59.
FULL TEXT  

The Muscular Dystrophies: From Genes to Therapies
Lovering et al.
ptjournal 2005;85:1372-1388.
ABSTRACT | FULL TEXT  

Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies
Chakkalakal et al.
FASEB J. 2005;19:880-891.
ABSTRACT | FULL TEXT  

Practice Parameter: Corticosteroid treatment of Duchenne dystrophy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Moxley et al.
Neurology 2005;64:13-20.
ABSTRACT | FULL TEXT  

Respiratory Care of the Patient with Duchenne Muscular Dystrophy: ATS Consensus Statement
Am. J. Respir. Crit. Care Med. 2004;170:456-465.
FULL TEXT  

Vertebral Fractures in Boys with Duchenne Muscular Dystrophy
Bothwell et al.
CLIN PEDIATR 2003;42:353-356.
ABSTRACT  

Corticosteroids in Duchenne Muscular Dystrophy: A Reappraisal
Wong and Christopher
J Child Neurol 2002;17:183-190.
ABSTRACT  

Prednisone Therapy in Becker's Muscular Dystrophy
Johnsen and Clinic
J Child Neurol 2001;16:870-871.
ABSTRACT  

Functional Enhancement of Patients with Duchenne Muscular Dystrophy with the Use of Robot-Manipulator Trainer Arms
Shramowiat et al.
Neurorehabil Neural Repair 1989;3:129-132.
ABSTRACT